Alpha-Hydroxytriazolam-D4 is a deuterated derivative of triazolam, a benzodiazepine commonly used for its anxiolytic and sedative properties. The "D4" designation indicates that the compound contains four deuterium atoms, which are isotopes of hydrogen, replacing standard hydrogen atoms in the molecular structure. This modification is often employed in research to enhance the stability and detectability of the compound in analytical studies, such as mass spectrometry. Alpha-Hydroxytriazolam-D4 retains the core characteristics of triazolam, including its mechanism of action, which involves modulation of the GABA-A receptor, leading to increased inhibitory neurotransmission in the central nervous system. The compound is typically used in pharmacological research to study the metabolism and pharmacokinetics of triazolam, as well as to investigate its potential therapeutic effects and side effects. As with other benzodiazepines, caution is advised due to the potential for dependence and withdrawal symptoms associated with prolonged use.

ALPHA-HYDROXYTRIAZOLAM-D4

145225-01-0: 4H-1,2,4Triazolo4,3-a1,4benzodiazepine-1-methanol, 8-chloro-6-(6-chlorophenyl-2,3,4,5-d4)-, Alpha-Hydroxytriazolam-D4,100/Mlinmethanol

CAS 145225-01-0: ALPHA-HYDROXYTRIAZOLAM-D4

Alpha-Hydroxytriazolam-D4

Ref: TR-LPM-TRI-925-100

Alpha-Hydroxytriazolam-D4, 1mg/ml in Methanol

Ref: TR-LPM-TRI-925-1LM

1’-Hydroxy Triazolam-d4

Ref: TR-H971327

Alpha-Hydroxytriazolam-D4, 0.1mg/ml in Methanol

Ref: TR-LPM-TRI-925-0.1LM

Alpha-Hydroxytriazolam-D4

Ref: TR-LPM-TRI-925